Patents by Inventor Claire Stines-Chaumeil

Claire Stines-Chaumeil has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Mutants of pyrroloquinoline quinine-dependent soluble glucose dehydrogenase
    Patent number: 8748145
    Abstract: The present invention relates to novel mutants of PQQ s-GDH containing an amino acid substitution in position 428 of the protein sequence of the wild type PQQ s-GDH of Acinetobacter calcoaceticus (SEQ.ID. NO:2). The invention also relates to the use of said PQQ s-GDH mutants for the development of glucose electrodes of interest in the assay of glucose, in particular of blood glucose in diabetic subjects, and for implementing biofuel cells that utilize glucose as fuel.
    Type: Grant
    Filed: July 20, 2010
    Date of Patent: June 10, 2014
    Assignee: Centre National de la Recherche Scientifique (C.N.R.S.)
    Inventors: Nicolas Mano, Claire Stines-Chaumeil, Fabien Durand
  • Mutants of Pyrroloquinoline Quinine-Dependent Soluble Glucose Dehydrogenase
    Publication number: 20120178115
    Abstract: The present invention relates to novel mutants of PQQ s-GDH containing an amino acid substitution in position 428 of the protein sequence of the wild type PQQ s-GDH of Acinetobacter calcoaceticus (SEQ.ID. NO:2). The invention also relates to the use of said PQQ s-GDH mutants for the development of glucose electrodes of interest in the assay of glucose, in particular of blood glucose in diabetic subjects, and for implementing biofuel cells that utilize glucose as fuel.
    Type: Application
    Filed: July 20, 2010
    Publication date: July 12, 2012
    Inventors: Nicolas Mano, Claire Stines-Chaumeil, Fabien Durand